Some Women Lack Interest in Sex With New Contraceptive

Share this content:
Some Women Lack Interest in Sex With New Contraceptive
Some Women Lack Interest in Sex With New Contraceptive

THURSDAY, Feb. 25, 2016 (HealthDay News) -- Almost one-quarter of women report lacking interest in sex at six months after initiating a new contraceptive method, according to a study published in the March issue of Obstetrics & Gynecology.

Amanda Boozalis, from the Washington University School of Medicine in St. Louis, and colleagues examined the effect of hormonal contraception on sexual desire in a cross-sectional analysis of 1,938 participants enrolled in the Contraceptive CHOICE Project. Participants completed telephone surveys at baseline and six months.

The researchers found that 23.9 percent of participants reported a lack of interest in sex at six months after initiating a new contraceptive method; 18.3 percent of copper intrauterine device (IUD) users (reference group) reported a lack of interest in sex. Lack of interest in sex was more prevalent among young women (younger than 18 years, adjusted odds ratio [aOR], 2.04), black women (aOR, 1.78), and those married or living with a partner (aOR, 1.82). Participants using depot medroxyprogesterone, the vaginal ring, and the implant more commonly reported lack of interest in sex, compared with copper IUD users (aORs, 2.61, 2.53, and 1.60, respectively). Hormonal IUD, oral contraceptive pill, and patch use were not associated with lack of interest in sex.

"Clinicians should be reassured that most women do not experience a reduced sex drive with the use of most contraceptive methods," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »